Week In Review: $1.5 Billion In China Deals With One Week Left In 2018 – Seeking Alpha


Week In Review: $1.5 Billion In China Deals With One Week Left In 2018  Seeking Alpha

Deals and Financings Xynomic Pharma, a US-China oncology company, has acquired a worldwide license to an mTORC1/2 inhibitor developed by Boehringer …

Read More…

Share This: